Utility Menu French

National Association of Pharmacy Regulatory Authorities

Provinces French

Main navigation French


Recherchez dans la base de données des Annexes nationales de médicaments

Commencez votre recherche en utilisant le nom générique du produit :

Recherche par annexe
Réinitialiser

ATTENTION : Tous les résultats de la recherche seront tirés du « National Drug Schedules » du site Web en anglais.

Nom du médicament (en anglais) Commentaire Annexe Date
Pinaverium bromidePDL I DEC / 13
PinazepamTS I JUN / 02
Pindolol or its saltsPDL I DEC / 13
Pioglitazone or its saltsPDL I DEC / 13
Pipecuronium bromidePDL I DEC / 13
Piperacetazine or its saltsPDL I DEC / 13
Piperazine and its salts II SEP / 98
Piperilate or its saltsPDL I DEC / 13
PipobromanPDL I DEC / 13
Pipotiazine or its saltsPDL I DEC / 13
Pipradol and any salt thereofTS I SEP / 98
Pirbuterol or its saltsPDL I DEC / 13
Pirenzepine or its saltsPDL I DEC / 13
Pirfenidone or its derivativesPDL I DEC / 13
Pirlimycin or its saltsPDL I DEC / 13
Piroxicam or its saltsPDL I DEC / 13
Pizotyline or its saltsPDL I DEC / 13
Plecanatide PDL I NOV / 19
Plerixafor or its saltsPDL I DEC / 13
Pneumococcal 7-valent conjugate vaccine II JAN / 04
Pneumococcal polysaccharide vaccines II FEB / 02
PodophyllotoxinPDL

When recommended for topical use.

I DEC / 13
PolidocanolPDL

When indicated for administration by injection.

I JAN / 16
Poliomyelitis vaccine II DEC / 98
Polyacrylamide II SEP / 98
Polyethylene glycol topical administration U
Polyethylene glycol 3350 as a single ingredient oral product indicated as a laxative to treat occasional constipation U JUL / 10
Polymyxin B or its salts or derivativesPDL

For human use - except for topical use or for local action in the oral cavity or nasal passages.

I DEC / 13
Polymyxin B or its salts or derivatives.PDL

For veterinary use - when sold in combination with other medicinal ingredients.

I APR / 16
Polymyxin B or its salts or derivatives..

for human, ophthalmic use

III JUN / 06
Polymyxin or its salts or derivatives for human, topical use U
Polysulfated glycosaminoglycanPDL I DEC / 13
Pomalidomide or its saltsPDL I FEB / 14
Ponatinib or its saltsPDL I MAY / 15
Poractant alfaPDL I DEC / 13
Porfimer or its saltsPDL I DEC / 13
PosaconazolePDL I DEC / 13
Potassium bromidePDL I DEC / 13
Potassium citratePDL

When recommended for the treatment of renal tubular acidosis and kidney stones.

I DEC / 13
Potassium gluconatePDL

For veterinary use - when sold or recommended for administration to cats.

I DEC / 13
Potassium para-aminobenzoatePDL

Except in preparations for topical use on the skin.

I DEC / 13
Potassium salts

In preparations for injection.

I DEC / 99
Potassium salts. in oral preparations containing more than 5 mmol per single dose [except potassium bromide, potassium gluconate when sold or recommended for administration to cats, potassium para-aminobenzoate, potassium citrate when recommended for the treatment of renal tubular acidosis and kidney stones] II DEC / 13
Povidone - iodine vaginal preparations, except in concentrations of 5% or less II SEP / 98
Pradofloxacin or their salts or derivativesPDL I MAR / 15
Pralatrexate or its saltsPDL I DEC / 18
Pralidoxime or its saltsPDL I DEC / 13
Pramipexole or its saltsPDL I DEC / 13
Pramoxine and its salts for ophthalmic or parenteral use II SEP / 98
Pramoxine and its salts.

for topical use on mucous membranes, except lozenges

III SEP / 98
Pramoxine and its salts.. for topical application on the skin, and including lozenges U DEC / 05
PrasteroneC3 I JUN / 02
Prasugrel or its saltsPDL I DEC / 13
Pravastatin or its saltsPDL I DEC / 13
Prazepam and its saltsTS I SEP / 98
PraziquantelPDL

For human use.

I DEC / 13
PraziquantelPDL

For veterinary use - except when sold for the treatment of the tapeworm Anoplocephala perfoliata in horses.

I DEC / 13
Prazosin or its saltsPDL I DEC / 13
Pregabalin or its salts or derivativesPDL I DEC / 13
Prenylamine or its saltsPDL I DEC / 13
Prilocaine and its salts

for ophthalmic or parenteral use

II SEP / 98
Prilocaine and its salts.

for topical use on mucous membranes, except lozenges

III SEP / 98
Primaquine or its saltsPDL I DEC / 13
PrimidonePDL

For human use.

I DEC / 13
ProbarbitalC2 I JUN / 02
Probenecid or its saltsPDL I DEC / 13
ProbucolPDL I DEC / 13
Procainamide or its saltsPDL I DEC / 13
Procaine and its salts for topical use on mucous membranes, except lozenges III SEP / 98
Procaine and its salts for ophthalmic or parenteral use II SEP / 98
Procarbazine or its saltsPDL I DEC / 13
Procaterol or its saltsPDL I DEC / 13
Prochlorperazine or its saltsPDL I DEC / 13
Procyclidine or its saltsPDL I DEC / 13
Prodilidine or its saltsPDL I DEC / 13
Profenamine or its saltsPDL

Including but not limited to ethopropazine.

I DEC / 13
Progesterone or its derivativesPDL

For veterinary use - except when recommended for use in progesterone implants indicated for growth promotion, melengestrol acetate in feed for the suppression of estrus in beef heifers.

I DEC / 13
Proguanil or its saltsPDL I DEC / 13
ProheptazineN I JUN / 02
Promazine or its saltsPDL

For human use.

I DEC / 13
Promethazine and its salts except for topical use II SEP / 98
Promethazine and its salts for topical use III SEP / 98
Propafenone or its saltsPDL I DEC / 13
PropallylonalC2 I JUN / 02
Propantheline and its salts II SEP / 98
Proparacaine and its salts for ophthalmic or parenteral use II SEP / 98
Proparacaine and its salts for topical use on mucous membranes, except lozenges III SEP / 98
ProperidineN I JUN / 02
PropiramN I JUN / 02
Propiverine or its saltsPDL I MAR / 17
PropofolPDL I DEC / 13
Propranolol or its saltsPDL I DEC / 13
Propylene glycol topical application U
Propylhexedrine II SEP / 98
Proquamezine [aminopromazine] and its salts

For internal use.

I SEP / 98
Prostaglandins or their salts or derivatives or analoguesPDL

Including but not limited to: Alprostadil, bimatoprost, cloprostenol, dinoprostone, epoprostenol, fluprostenol, latanoprost, latanoprostene bunod, lubiprostone, misoprostol, tafluprost, travoprost, treprostinil, unoprostone.

I AUG / 15
Protamine and its salts II SEP / 98
Prothipendyl hydrochloridePDL I DEC / 13
ProtirelinPDL I DEC / 13
Protriptyline or its saltsPDL I DEC / 13

213 résultats


Footnotes

  • C1: Drug is in the Controlled Drugs and Substances Act and Part I of the Schedule to Part G of the Food and Drug Regulations
  • C2: Drug is in the Controlled Drugs and Substances Act and Part II of the Schedule to Part G of the Food and Drug Regulations
  • C3: Drug is in the Controlled Drugs and Substances Act and Part III of the Schedule to Part G of the Food and Drug Regulations
  • C4: drug is in the Controlled Drugs and Substances Act
  • C5: drug is in the Regulations Under CDSA
  • CR: drug has been recommended for addition to the Controlled Drugs and Substances Act
  • CR-C: drug has been recommended for addition to the Controlled Drugs and Substances Act, Part G of the Food and Drug Regulations
  • CR-N: drug has been recommend for addition to the Controlled Drugs and Substances Act, Narcotic Control Regulations
  • CR-TS: drug has been recommended for addition to the Controlled Drugs and Substances Act, Benzodiazepines and Other Targeted Substances Regulations
  • F1: drug appears in Part I of Schedule F to the Food and Drugs Act and Regulations
  • F2: drug appears in Part II of Schedule F to the Food and Drugs Act and Regulations
  • FR: drug has been recommended for addition to Schedule F to the Food and Drugs Act and Regulations ("Schedule F Recommended")
  • N: drug is in the Narcotic Control Regulations under the Controlled Drugs and Substances Act
  • NR: drug has not been reviewed by NDSAC
  • PDL: drug is in the Prescription Drug List (effective Dec. 19, 2013)
  • R: drug is in Part J of the Food and Drugs Act and listed in the Controlled Drugs and Substances Act
  • TS: drug is in the Benzodiazepines and Other Targeted Substances Regulations under the Controlled Drugs and Substances Act
  • U: drug has been reviewed by NDSAC and is unscheduled